 SOUTH SAN FRANCISCO, Calif., April 06, 2022 GLOBE NEWSWIRE -- Day One Biopharmaceuticals Nasdaq: DAWN, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 3:45 p.m. ET. 